3-Bromo-1H-indazole-5-carbaldehyde

Catalog No. :
ACQRND314
CAS No. :
1086391-08-3
Molecular Formula :
C8H5BrN2O
Molecular Weight :
225.04

IUPAC Name:3-bromo-2H-indazole-5-carbaldehyde

3-Bromo-1H-indazole-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$61.00Login to see priceIn stockInquiry
1g96%$191.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-1H-indazole-5-carbaldehyde
IUPAC Name3-bromo-2H-indazole-5-carbaldehyde
MDL No.MFCD11499015
Molecular FormulaC8H5BrN2O
Molecular Weight225.04
SMILESO=CC1=CC2=C(NN=C2Br)C=C1
InChI KeyHUUXQTDSLDFUQW-UHFFFAOYSA-N
SynonymW-204674 | 3-Bromo-indazole-5-carboxaldehyde 95+% | MFCD11499015 | SCHEMBL182436 | 3-BROMO-INDAZOLE-5-CARBOXALDEHYDE | 3-Bromo-1H-indazole-5-carboxaldehyde, 95% | DTXSID70672253 | AMY33162 | FT-0749623 | J-511795 | 3-Bromo-1H-indazole-5-carboxaldehyde | 1
CAS No.1086391-08-3
PubChem CID45790260

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACQRND314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACROMA466 route compound structure diagram
    ACROMA466253801-04-6 In Stock
  4. Then
  5. ACQRND314 route product structure diagram
    ACQRND3141086391-08-3 In Stock
Inquiry

2. ACQRND314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKSZQ125 route compound structure diagram
    ACKSZQ12593556-88-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACROMA466 route compound structure diagram
    ACROMA466253801-04-6 In Stock
  6. Then
  7. ACQRND314 route product structure diagram
    ACQRND3141086391-08-3 In Stock
Inquiry

Comments (0)